During the past decade, VA Connecticut Healthcare System conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 37 clinical trials were completed, i.e. on average, 86% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 10 clinical trials were completed. i.e. 47.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VA Connecticut Healthcare System" #1 sponsor was "Yale University" with 73 trials, followed by "VA Connecticut Healthcare System" with 21 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored, "National Institute on Drug Abuse (NIDA)" with 3 trials sponsored and "VA Office of Research and Development" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Connecticut Healthcare System" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 22 trials as a collaborator, "VA Connecticut Healthcare System" with 19 trials as a collaborator, "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 9 trials as a collaborator, "United States Department of Defense" with 6 trials as a collaborator and "Yale University" with 5 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "VA Connecticut Healthcare System" are "Schizophrenia" (12 trials), "Alcohol Dependence" (11 trials), "Opioid-Related Disorders" (9 trials), "Alcoholism" (7 trials) and "Cocaine-Related Disorders" (7 trials). Many other conditions were trialed in "VA Connecticut Healthcare System" in a lesser frequency.

Most popular intervention types in "VA Connecticut Healthcare System" are "Drug" (82 trials), "Behavioral" (33 trials), "Other" (11 trials), "Procedure" (7 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "THC" (5 trials), "Buprenorphine" (3 trials), "Delta-9-THC" (3 trials) and "Naltrexone" (3 trials). Other intervention names were less common.

The vast majority of trials in "VA Connecticut Healthcare System" are 114 trials for "All" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "VA Connecticut Healthcare System". undefined are not yet recruiting, 15 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 81 completed trials in VA Connecticut Healthcare System, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in VA Connecticut Healthcare System, 19 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 36 trials that are defined as “Not Applicable".